MENU
+Compare
NVO
Stock ticker: NYSE
AS OF
Oct 8, 04:59 PM (EDT)
Price
$59.62
Change
+$0.60 (+1.02%)
Capitalization
269.4B

NVO Novo-Nordisk A/S Forecast, Technical & Fundamental Analysis

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more

NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NVO with price predictions
Oct 07, 2025

NVO in -0.22% downward trend, sliding for three consecutive days on September 30, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NVO declined for three days, in of 277 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for NVO moved out of overbought territory on September 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on October 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NVO as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

NVO broke above its upper Bollinger Band on September 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for NVO just turned positive on October 03, 2025. Looking at past instances where NVO's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

NVO moved above its 50-day moving average on October 01, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NVO crossed bullishly above the 50-day moving average on September 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVO advanced for three days, in of 337 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 288 cases where NVO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.950) is normal, around the industry mean (9.701). P/E Ratio (15.082) is within average values for comparable stocks, (24.631). Projected Growth (PEG Ratio) (1.498) is also within normal values, averaging (2.046). Dividend Yield (0.029) settles around the average of (0.027) among similar stocks. P/S Ratio (5.373) is also within normal values, averaging (3.590).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVO is expected to report earnings to fall 11.11% to 82 cents per share on November 05

Novo-Nordisk A/S NVO Stock Earnings Reports
Q3'25
Est.
$0.83
Q2'25
Est.
$0.93
Q1'25
Beat
by $5.64
Q4'24
Beat
by $5.46
Q3'24
Beat
by $5.24
The last earnings report on August 06 showed earnings per share of 92 cents, missing the estimate of 93 cents. With 3.62M shares outstanding, the current market capitalization sits at 269.40B.
A.I.Advisor
published Dividends

NVO paid dividends on August 26, 2025

Novo-Nordisk A/S NVO Stock Dividends
А dividend of $0.58 per share was paid with a record date of August 26, 2025, and an ex-dividend date of August 18, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PCEF20.140.10
+0.50%
Invesco CEF Income Composite ETF
TEKX41.51N/A
N/A
SPDR Galaxy TransformativeTechAcclrtrETF
SCHB25.82-0.11
-0.42%
Schwab US Broad Market ETF™
EWUS41.12-0.41
-0.99%
iShares MSCI United Kingdom Small-Cp ETF
FDM74.73-0.87
-1.15%
First Trust Dow Jones Sel MicroCap ETF

NVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been closely correlated with NONOF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVO jumps, then NONOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-1.06%
NONOF - NVO
70%
Closely correlated
-2.18%
TECH - NVO
36%
Loosely correlated
-4.41%
GMAB - NVO
35%
Loosely correlated
-2.01%
MRK - NVO
34%
Loosely correlated
-1.34%
BCAB - NVO
33%
Loosely correlated
-3.05%
More

Groups containing NVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-1.06%
Pharmaceuticals: Major
industry (61 stocks)
41%
Loosely correlated
-0.10%
Pharmaceuticals
industry (386 stocks)
35%
Loosely correlated
+0.46%